10.25USD-5.27%Mkt Cap: 59.73M USDP/E: 6.25Last update: 2026-05-26
Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use …
Industry Peers
Medical Instruments & Supplies154.90BUSDP/E 53.1
91.05BDKKP/E 43.3
79.04BEURP/E 34.6
40.95BUSDP/E 25.9
30.53BUSDP/E 31.7
30.41BUSDP/E 20.2
25.86BCHFP/E 40.2
22.52BUSDP/E 42.7
Indicators:|
Key Statistics
Company
Market Cap59.73M USD
Enterprise Value—
Revenue (TTM)26.69K USD
Gross Profit26.69K USD
Net Income (TTM)9.17M USD
Revenue/Share0.0050 USD
Last Price10.25 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)6.25
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S2362.51
P/B1.19
EPS (TTM)1.64
EPS (Forward)—
52W Range
7.57037% of range14.76
52W High14.76 USD
52W Low7.570 USD
Profitability
Gross Margin100.00%
Oper. Margin-9660.55%
EBITDA Margin0.00%
Profit Margin89.00%
ROE19.98%
ROA19.93%
Growth
Revenue Growth-82.60%
Earnings Growth329.30%
Cash Flow & Leverage
Operating CF570.94K USD
CapEx (TTM)—
FCF Margin375.63%
FCF Yield0.17%
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio0.08
Quick Ratio—
Book Value/Sh9.069 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield0.52%
Payout Ratio0.00%
Ex-Div DateJan 5, 2018
Pay DateJan 12, 2018
Analyst Consensus
Rating—
Target (Mean)22.50 USD
Target Range22.00 USD – 23.00 USD
# Analysts2
Ownership
Shares Out.5.83M
Float2.57M
Insiders49.02%
Institutions7.00%
Short Interest
Short Ratio0.3d
Short % Float0.12%
Short % Out.0.06%
Shares Short3.55K
Short (prev mo.)3.28K
Technical
SMA 5010.29 (-0.4%)
SMA 20011.92 (-14.0%)
Beta0.29
S&P 52W Chg28.31%
Avg Vol (30d)7.63K
Avg Vol (10d)9.94K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—